[go: up one dir, main page]

GB0225042D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB0225042D0
GB0225042D0 GB0225042A GB0225042A GB0225042D0 GB 0225042 D0 GB0225042 D0 GB 0225042D0 GB 0225042 A GB0225042 A GB 0225042A GB 0225042 A GB0225042 A GB 0225042A GB 0225042 D0 GB0225042 D0 GB 0225042D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0225042A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTRE
LIMITED
Ionix Pharmaceuticals Ltd
Kyowa Kirin Services Ltd
Original Assignee
Ionix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/508,336 priority Critical patent/US7666876B2/en
Application filed by Ionix Pharmaceuticals Ltd filed Critical Ionix Pharmaceuticals Ltd
Priority to GB0225042A priority patent/GB0225042D0/en
Publication of GB0225042D0 publication Critical patent/GB0225042D0/en
Priority to CN038063646A priority patent/CN1642577B/en
Priority to JP2003577852A priority patent/JP2005527535A/en
Priority to PCT/GB2003/001184 priority patent/WO2003080022A2/en
Priority to PCT/GB2003/001183 priority patent/WO2003080021A2/en
Priority to ES03715087T priority patent/ES2325364T3/en
Priority to AT03712380T priority patent/ATE410187T1/en
Priority to NZ535973A priority patent/NZ535973A/en
Priority to AT03715087T priority patent/ATE422902T1/en
Priority to EP03712380A priority patent/EP1499360B1/en
Priority to PT03715087T priority patent/PT1513493E/en
Priority to SI200331468T priority patent/SI1499360T1/en
Priority to EP07020868A priority patent/EP1878446A3/en
Priority to EP03715087A priority patent/EP1513493B8/en
Priority to DE60323958T priority patent/DE60323958D1/en
Priority to IL16412903A priority patent/IL164129A0/en
Priority to DK03712380T priority patent/DK1499360T3/en
Priority to CA002479718A priority patent/CA2479718A1/en
Priority to AU2003216842A priority patent/AU2003216842B2/en
Priority to DE60326231T priority patent/DE60326231D1/en
Priority to KR1020117000035A priority patent/KR20110005919A/en
Priority to CA2479711A priority patent/CA2479711C/en
Priority to DK03715087T priority patent/DK1513493T3/en
Priority to BRPI0308527-9A priority patent/BRPI0308527B1/en
Priority to ES03712380T priority patent/ES2315485T3/en
Priority to KR1020047014665A priority patent/KR101030403B1/en
Priority to MXPA04009055A priority patent/MXPA04009055A/en
Priority to GB0318346A priority patent/GB2397016B/en
Priority to US10/508,315 priority patent/US20050142072A1/en
Priority to JP2003577851A priority patent/JP4728580B2/en
Priority to NZ535972A priority patent/NZ535972A/en
Priority to AU2003219282A priority patent/AU2003219282A1/en
Priority to IL164129A priority patent/IL164129A/en
Priority to US11/798,384 priority patent/US20070231269A1/en
Priority to US12/588,528 priority patent/US20100041624A1/en
Priority to JP2010071698A priority patent/JP2010174029A/en
Priority to US12/929,279 priority patent/US20110105551A1/en
Ceased legal-status Critical Current

Links

GB0225042A 2002-03-19 2002-10-28 Pharmaceutical composition Ceased GB0225042D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
US10/508,336 US7666876B2 (en) 2002-03-19 2002-03-19 Buprenorphine formulations for intranasal delivery
GB0225042A GB0225042D0 (en) 2002-10-28 2002-10-28 Pharmaceutical composition
AU2003219282A AU2003219282A1 (en) 2002-03-19 2003-03-19 Analgesics for nasal administration
CA002479718A CA2479718A1 (en) 2002-03-19 2003-03-19 Analgesics for nasal administration
DE60326231T DE60326231D1 (en) 2002-03-19 2003-03-19 ANALGESIC
PCT/GB2003/001184 WO2003080022A2 (en) 2002-03-19 2003-03-19 Analgesics for nasal administration
PCT/GB2003/001183 WO2003080021A2 (en) 2002-03-19 2003-03-19 Formulation comprising buprenorphine
ES03715087T ES2325364T3 (en) 2002-03-19 2003-03-19 ANALGESICS.
CA2479711A CA2479711C (en) 2002-03-19 2003-03-19 Formulation
NZ535973A NZ535973A (en) 2002-03-19 2003-03-19 Opioid analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) for nasal administration
AT03715087T ATE422902T1 (en) 2002-03-19 2003-03-19 ANALGESICS
EP03712380A EP1499360B1 (en) 2002-03-19 2003-03-19 Formulation comprising buprenorphine
PT03715087T PT1513493E (en) 2002-03-19 2003-03-19 Analgesics
SI200331468T SI1499360T1 (en) 2002-03-19 2003-03-19 Formulation comprising buprenorphine
EP07020868A EP1878446A3 (en) 2002-03-19 2003-03-19 Formulation comprising buprenorphine
EP03715087A EP1513493B8 (en) 2002-03-19 2003-03-19 Analgesics
DE60323958T DE60323958D1 (en) 2002-03-19 2003-03-19 BUPRENORPHINE CONTAINING PREPARATION
IL16412903A IL164129A0 (en) 2002-03-19 2003-03-19 Formulation for intranalsal administration
DK03712380T DK1499360T3 (en) 2002-03-19 2003-03-19 Formulation comprising buprenorphine
CN038063646A CN1642577B (en) 2002-03-19 2003-03-19 Preparations containing buprenorphine
AU2003216842A AU2003216842B2 (en) 2002-03-19 2003-03-19 Formulation comprising buprenorphine
KR1020117000035A KR20110005919A (en) 2002-03-19 2003-03-19 Formulations containing buprenorphine
JP2003577852A JP2005527535A (en) 2002-03-19 2003-03-19 Analgesics
AT03712380T ATE410187T1 (en) 2002-03-19 2003-03-19 PREPARATION CONTAINING BUPRENORPHINE
DK03715087T DK1513493T3 (en) 2002-03-19 2003-03-19 analgesics
BRPI0308527-9A BRPI0308527B1 (en) 2002-03-19 2003-03-19 Aqueous solution suitable for intranasal administration, process for preparing an aqueous solution, nasal delivery device, and use of an aqueous solution
ES03712380T ES2315485T3 (en) 2002-03-19 2003-03-19 FORMULATION UNDERSTANDING BUPRENORFINA.
KR1020047014665A KR101030403B1 (en) 2002-03-19 2003-03-19 Formulations containing buprenorphine
MXPA04009055A MXPA04009055A (en) 2002-03-19 2003-03-19 Formulation comprising buprenorphine.
GB0318346A GB2397016B (en) 2002-03-19 2003-03-19 Intranasal analgesic composition containing buprenorphine
US10/508,315 US20050142072A1 (en) 2002-03-19 2003-03-19 Analgesics for nasal administration
JP2003577851A JP4728580B2 (en) 2002-03-19 2003-03-19 Formulation
NZ535972A NZ535972A (en) 2002-03-19 2003-03-19 Formulation comprising buprenorphine
IL164129A IL164129A (en) 2002-03-19 2004-09-19 Intranasal analgesic composition comprising buprenorphine
US11/798,384 US20070231269A1 (en) 2002-03-19 2007-05-14 Analgesics
US12/588,528 US20100041624A1 (en) 2002-03-19 2009-10-19 Buprenorphine formulations for intranasal delivery
JP2010071698A JP2010174029A (en) 2002-03-19 2010-03-26 Analgesic
US12/929,279 US20110105551A1 (en) 2002-03-19 2011-01-12 Analgesics for nasal administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0225042A GB0225042D0 (en) 2002-10-28 2002-10-28 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB0225042D0 true GB0225042D0 (en) 2002-12-04

Family

ID=9946713

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0225042A Ceased GB0225042D0 (en) 2002-03-19 2002-10-28 Pharmaceutical composition

Country Status (1)

Country Link
GB (1) GB0225042D0 (en)

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
AU2003291103A8 (en) Pharmaceutical composition
IL164547A0 (en) Pharmaceutical composition
GB2391473B (en) Pharmaceutical compositions
AU2003250372A8 (en) Pharmaceutical composition
HU0301154D0 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
GB0317663D0 (en) Pharmaceutical composition
GB0229258D0 (en) Medicinal compositions
GB0213481D0 (en) Pharmaceutical compositions
GB0300885D0 (en) Pharmaceutical composition
GB0306933D0 (en) Pharmaceutical composition
GB0201520D0 (en) Pharmaceutical uses
GB0307869D0 (en) Pharmaceutical composition
PL370907A1 (en) Pharmaceutical compositions
GB0307862D0 (en) Pharmaceutical composition
GB0307864D0 (en) Pharmaceutical composition
GB0307867D0 (en) Pharmaceutical composition
GB0217703D0 (en) Pharmaceutical composition
EP1547593A4 (en) Medicinal composition
GB0307865D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: CENTRE

Free format text: FORMER APPLICANT(S): IONIX PHARMACEUTICALS LTD

Owner name: IONIX PHARMACEUTICALS LTD

Free format text: FORMER APPLICANT(S): IONIX PHARMACEUTICALS LTD

Owner name: LIMITED

Free format text: FORMER APPLICANT(S): IONIX PHARMACEUTICALS LTD

Owner name: WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINI

Free format text: FORMER APPLICANT(S): IONIX PHARMACEUTICALS LTD

AT Applications terminated before publication under section 16(1)